The Diabetes Prevention Program Outcomes Study AD/ADRD... | Clinical Trial | StuddyBuddy@endsection The Diabetes Prevention Program Outcomes Study AD/ADRD Project
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Enrolling By Invitation NCT05704309

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

Conditions: Diabetes, Alzheimer Disease, Dementia, Vascular, Dementia, PreDiabetes

Sex: All
Healthy volunteers: 1
Enrollment: 1976
Sponsor: Marinella Temprosa

Location: United States

Summary

The DPPOS AD/ADRD project will address the overarching question: What are the determinants and the nature of cognitive impairment among persons with pre-diabetes (PreD) and type 2 diabetes (T2D), who are a high-risk group for cognitive impairment and represent a large fraction of the United States (US) population? This U19 proposal addresses the National Alzheimer's Project Act goal to "prevent, halt, or reverse AD" in the high-risk group of persons with pre-diabetes and type 2 diabetes, who represent over half of the population aged 60 years and older in the US.

Eligibility Criteria

Inclusion Criteria:All surviving participants originally randomized in the Diabetes Prevention ProgramFor Brain Imaging subcohort, only participants aged 55 years and older and those without contraindication to MRI will be included. Contraindications to MRI include the inability to lie flat, claustrophobia, and the presence of indwelling metallic objects, medical or non-medical, that are not 3T MRI compatible.Exclusion Criteria:-

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05704309). StuddyBuddy aggregates publicly available trial information.